Protein predicts prostate cancer spread
By Nathan Seppa
From San Francisco, at the 91st Annual Meeting of the American Association for Cancer Research
Prostate cancer patients who harbor high concentrations of a protein called thymosine beta-15 in their tumors face an increased risk that the cancer will spread, new research shows.
Researchers at Harvard Medical School in Boston tracked 32 prostate cancer patients who received only radiation therapy. At the start of the study, the scientists measured the thymosine beta-15 concentrations in each man’s tumor tissue.